In the News January 8, 2019

Business Monitor Online | Mylan Launches Mesalamine Generic in US

Alston & Bird is noted for representing Mylan Pharmaceuticals Inc. in a drug patent dispute with Shire Development LLC.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.